Institutional investors purchased a net $7.8 million shares of TXMD during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 72.87% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 432.0 Thousand shares of TherapeuticsMD Inc